Nyakale N - Search Results

1

Chemokine Receptor-4 Targeted PET/CT Imaging with ⁶⁸Ga-Pentixafor in Head and Neck Cancer-A Comparison with ¹⁸F-FDG and CXCR4 Immunohistochemistry.

Hadebe B, Harry L, Gabela L, Masikane S, Patel M, Zwane S, Pillay V, Bipath P, Cebekhulu N, Nyakale N, Ramdass P, Msimang M, Aldous C, Sathekge M, Vorster M. Hadebe B, et al. Among authors: nyakale n. Diagnostics (Basel). 2024 Jun 28;14(13):1375. doi: 10.3390/diagnostics14131375. Diagnostics (Basel). 2024. PMID: 39001265 Free PMC article.

2

Clinical and brain SPECT scan response to zolpidem in patients after brain damage.

Nyakale NE, Clauss RP, Nel W, Sathekge M. Nyakale NE, et al. Arzneimittelforschung. 2010;60(4):177-81. doi: 10.1055/s-0031-1296269. Arzneimittelforschung. 2010. PMID: 20486466

3

Blood-brain barrier integrity in a zolpidem-responder patient.

Nyakale NE, Clauss RP, Nel HW, Sathekge MM. Nyakale NE, et al. S Afr Med J. 2012 Jul 31;102(10):790-1. doi: 10.7196/samj.5993. S Afr Med J. 2012. PMID: 23034205 Free article.

4

⁶⁸Ga-PSMA imaging of metastatic breast cancer.

Sathekge M, Modiselle M, Vorster M, Mokgoro N, Nyakale N, Mokaleng B, Ebenhan T. Sathekge M, et al. Among authors: nyakale n. Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1482-3. doi: 10.1007/s00259-015-3066-x. Epub 2015 May 1. Eur J Nucl Med Mol Imaging. 2015. PMID: 25931036 No abstract available.

5

Appropriate indications for positron emission tomography/computed tomography, 2015.

Vorster M, Doruyter A, Brink A, Mkhize S, Holness J, Malan N, Nyakale N, Warwick JM, Sathekge M; College of Nuclear Physicians of South Africa. Vorster M, et al. Among authors: nyakale n. S Afr Med J. 2015 Oct 16;106(1 Pt 2):105-22. doi: 10.7196/SAMJ.2016.v106i1.10181. S Afr Med J. 2015. PMID: 26792318 Review.

6

Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.

Lawal IO, Nyakale NE, Harry LM, Lengana T, Mokgoro NP, Vorster M, Sathekge MM. Lawal IO, et al. Nucl Med Commun. 2017 Mar;38(3):222-227. doi: 10.1097/MNM.0000000000000640. Nucl Med Commun. 2017. PMID: 28002173

7

The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma.

Lawal IO, Nyakale NE, Harry LM, Modiselle MR, Ankrah AO, Msomi AP, Mokgoro NP, Boshomane TG, de Wiele CV, Sathekge MM. Lawal IO, et al. Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2025-2033. doi: 10.1007/s00259-017-3766-5. Epub 2017 Jun 28. Eur J Nucl Med Mol Imaging. 2017. PMID: 28660348

8

18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma.

Lawal IO, Ankrah AO, Popoola GO, Nyakale NE, Boshomane TG, Reyneke F, Lengana T, Vorster M, Sathekge MM. Lawal IO, et al. Nucl Med Commun. 2018 Nov;39(11):1005-1012. doi: 10.1097/MNM.0000000000000905. Nucl Med Commun. 2018. PMID: 30198974

9

The College of Nuclear Physicians of South Africa Practice Guidelines on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours.

Lawal I, Louw L, Warwick J, Nyakale N, Steyn R, Lengana T, Lengana T, Ellmann A, Kotze T, Vangu M, Vorster M, Sathekge M. Lawal I, et al. Among authors: nyakale n. S Afr J Surg. 2018 Sep;56(3):55-64. S Afr J Surg. 2018. PMID: 30264945 Review.

10

South African guidelines for receptor radioligand therapy (RLT) with Lu-177-PSMA in prostate cancer.

Vorster M, Warwick J, Lawal IO, Du Toit P, Vangu M, Nyakale NE, Steyn R, Gutta AA, Hart G, Mutambirwa S, Ellmann A, Sathekge MM. Vorster M, et al. Among authors: nyakale ne. S Afr J Surg. 2019 Dec;57(4):45-51. S Afr J Surg. 2019. PMID: 31773936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters